Nano-Methoxatin Improves Ischemia-Reperfusion Injury in Torsion-Detorsion Model of Ovary

Using a rat ovary model, protective effects of nano-methoxatin (NMXTN) were studied on ischemia-reperfusion injury. Following randomization of forty-eight healthy female Wistar rats ~250 g, the animals were subjected to eight experimental groups (n = 6): Group SHAM: Only laparotomy was performed. Group IS: Only a 3-hour ischemia was performed. Group IS/Oil: Only a 3-hour ischemia was performed and 50 µl soybean oil alone (Solvent of MXTN) was administered 30 min before cessation of ischemia. Group IS/REP: The procedure included a 3-hour ischemia followed by a 3-hour reperfusion and 50 µl soybean oil alone was administered 30 min before cessation of ischemia. Group IS/MXTN: The procedure included a 3-hour ischemia only and 50 µl (0.3 mmol/l/IP) of MXTN 30 min before cessation of ischemia. Group IS/NMXTN: The procedure included a 3-hour ischemia only and 50 µl (0. 3 mmol/l/IP) of NMXTN 30 min before cessation of ischemia. Group IS/REP/MXTN: The procedure included a 3-hour ischemia, a 3-hour reperfusion and 20 µl (0.3 mmol/l) of MXTN 30 min before cessation of ischemia. Group IS/REP/NMXTN: The procedure included a 3-hour ischemia, a 3-hour reperfusion and 20 µl (0.3 mmol/l) of NMXTN 30 min before cessation of ischemia. Significantly amended development of ischemia/reperfusion tissue injury was observed in animals treated with NMXTN compared to those of other groups (p = 0.001). Mean values of biochemical indices were significantly higher than those observed for other groups (p = 0.001). Significantly lower values of MDA were observed in IS/REP/NMXTN animals compared to those of other groups (p = 0.001). Where ovarian tissue is exposed to ischemia intraperitoneal administration of NMXTN could bear clinical benefits in diminishing ischemia-reperfusion injury.